On Monday the board of directors of US pharmaceutical company Eli Lilly and Company (NYSE:LLY) declared a dividend of USD1.50 per share of common stock for the third quarter of 2025.
This amount is unchanged from the previous quarterly dividend.
Shareholders of record at the close of business on 15 August 2025 will receive the dividend on 10 September 2025.
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Ridgetech reports net income of USD10.20m in fiscal year 2025
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea